[
  {
    "ts": "2026-01-23T00:00:03+00:00",
    "headline": "Podcast: Stocks Rise as Tariff Tensions Cool",
    "summary": "The gains occur as investors look for more details about President Trump's desire to annex Greenland. Plus, Intel predicts further losses next quarter in an after-hours earnings report. And shares in Abbott Laboratories fall after the company misses sales expectations.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-22-2026/card/podcast-stocks-rise-as-tariff-tensions-cool-tDi4j8GoDf8BPnjJawUX?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "b2fb7feb-385c-32b2-84bb-6d7ff3950281",
      "content": {
        "id": "b2fb7feb-385c-32b2-84bb-6d7ff3950281",
        "contentType": "STORY",
        "title": "Podcast: Stocks Rise as Tariff Tensions Cool",
        "description": "",
        "summary": "The gains occur as investors look for more details about President Trump's desire to annex Greenland. Plus, Intel predicts further losses next quarter in an after-hours earnings report. And shares in Abbott Laboratories fall after the company misses sales expectations.",
        "pubDate": "2026-01-23T00:00:03Z",
        "displayTime": "2026-01-23T00:00:03Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b2fb7feb-385c-32b2-84bb-6d7ff3950281/podcast-stocks-rise-as.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-22-2026/card/podcast-stocks-rise-as-tariff-tensions-cool-tDi4j8GoDf8BPnjJawUX?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-23T02:16:12+00:00",
    "headline": "Abbott Stock Suffers Worst Drop in More Than 20 Years",
    "summary": "Abbott Laboratories stock slid Thursday after the medical-products maker reported disappointing results, hit by a slump in the division that makes baby formula and nutrition shakes. Abbott shares closed 10% lower, its sharpest one-day fall since 2002.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-22-2026/card/abbott-stock-drops-on-slumping-sales-of-baby-formula-and-nutrition-shakes-ZNaIuJKaLdwSvBTtd0ca?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "6dd5222c-1b5d-34e6-854c-8bde4c2a82b1",
      "content": {
        "id": "6dd5222c-1b5d-34e6-854c-8bde4c2a82b1",
        "contentType": "STORY",
        "title": "Abbott Stock Suffers Worst Drop in More Than 20 Years",
        "description": "",
        "summary": "Abbott Laboratories stock slid Thursday after the medical-products maker reported disappointing results, hit by a slump in the division that makes baby formula and nutrition shakes. Abbott shares closed 10% lower, its sharpest one-day fall since 2002.",
        "pubDate": "2026-01-23T02:16:12Z",
        "displayTime": "2026-01-23T02:16:12Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/6dd5222c-1b5d-34e6-854c-8bde4c2a82b1/abbott-stock-suffers-worst.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-22-2026/card/abbott-stock-drops-on-slumping-sales-of-baby-formula-and-nutrition-shakes-ZNaIuJKaLdwSvBTtd0ca?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-23T06:30:00+00:00",
    "headline": "AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next.",
    "summary": "AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers Squibb face similar patent cliffs.",
    "url": "https://www.barrons.com/articles/abbvie-dodged-a-patent-disaster-and-shares-gained-460-merck-and-bristol-myers-are-next-5968f3cd?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ff057859-25cc-38ab-bf6d-78ba37dc9314",
      "content": {
        "id": "ff057859-25cc-38ab-bf6d-78ba37dc9314",
        "contentType": "STORY",
        "title": "AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next.",
        "description": "",
        "summary": "AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers Squibb face similar patent cliffs.",
        "pubDate": "2026-01-23T06:30:00Z",
        "displayTime": "2026-01-23T06:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ff057859-25cc-38ab-bf6d-78ba37dc9314/abbvie-dodged-a-patent.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/90655360b7a4e125d540f8474523bc7f",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6BytADf.wdgQOFbGSuj0IA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/90655360b7a4e125d540f8474523bc7f.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aiR.2Irm6EXEA73p_uJuJQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/90655360b7a4e125d540f8474523bc7f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/abbvie-dodged-a-patent-disaster-and-shares-gained-460-merck-and-bristol-myers-are-next-5968f3cd?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]